Drug
Teriparatide
Teriparatide: highest development phase Phase 3, developed by Eli Lilly. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Eli Lilly
Trials
| Drug | Phase | Indication |
|---|---|---|
| teriparatide NCT00532207 | Phase 3 | Osteoporosis, Post-Menopausal |
Latest
No recent events.
Follow Teriparatide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.